| 203.90 Delayed Data As of 10:04am ET |  +0.52 / +0.26%Today’s Change | 132.75 Today|||52-Week Range 217.16 | +40.89% Year-to-Date |
| Previous close | 203.38 |
| Today’s open | 202.34 |
| Day’s range | 202.34 - 205.49 |
| Volume | 10,212 |
| Average volume (3 months) | 163,942 |
| Market cap | $7.6B |
| Earnings growth (last year) | -24.48% |
| Earnings growth (this year) | +10.53% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +11.04% |
| P/E ratio | 82.5 |
| Price/Sales | 11.36 |
| Price/Book | 6.54 |
| Today’s change | Today’s % change | |
|---|---|---|
| NBIXNeurocrine Bioscienc... | +1.96 | +2.02% |
| MRNAModerna Inc | +0.23 | +1.48% |
| BLUEbluebird bio Inc | -1.74 | -1.90% |
| ONCESpark Therapeutics I... | -0.82 | -0.81% |
| Next reporting date | October 29, 2019 |
| EPS forecast (this quarter) | $1.05 |
| Annual revenue (last year) | $714.0M |
| Annual profit (last year) | $96.0M |
| Net profit margin | 13.44% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Minneapolis, Minnesota |
